Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-08-29
2006-08-29
Jiang, Shaojia A. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S161000, C514S171000, C514S406000, C514S570000, C536S053000, C435S007240
Reexamination Certificate
active
07098195
ABSTRACT:
The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated N-acetylglucosamines.
REFERENCES:
patent: 5627290 (1997-05-01), Iida et al.
Alon R., et al., “Distinct Cell Surface Ligands Mediate T Lymphocyte Attachment and Rolling on P and E Selectin Under Physiological Flow,”J. Cell Biol. 127(5):1485-1495 (1994).
Berg EL., et al., “The Cutaneous Lymphocyte Antigen is a Skin Lymphocyte Homing Receptor for the Vascular Lectin Endothelial Cell-Leukocyte Adhesion Molecule,”J. Exp. Med.174:1461-1466 (1991).
Bernacki RJ, et al., “Biochemical Characteristics, Metabolism, and Antitumor Activity of Severeral Acetylated Hexosamines,”J. Supramol. Struct. 7(2):235-250 (1977).
Blander JM, et al., “α(1,3)-Fucosyltransferase VII and α(2,3)-Sialyltransferase IV are up-Regulated in Activated CD4 T Cells and Maintained After Their Differentiation Into Th1 and Migration Into Inflammatory Sites,”J. Immunology163(7):3746-3752 (1999).
Borges E., et al., “P-selectin Glycoprotein Ligand-1 (PSGL-1) on T Helper 1 But Not on T Helper 2 Cells Binds to P-Selectin and Supports Migration Into Inflamed Skin,”J. Biol. Chem.272(45):28786-28792 (1997).
Borowitz MJ., et al., “Abnormalities of Circulating T-cell Subpopulations in Patients with Cutaneous T-cell Lymphoma: Cutaneous Lymphocyte-Associated Antigen Expression on T Cells Correlates with Extent of Disease,”Leukemia7(6):859-863 (1993).
Burdick MM, et al., “Glycolipids Support E-selectin-Specific Strong Cell Tethering Under Flow,”Biochem. Biophys. Res. Commun.284(1):42-49 (2001).
Davis RE, et al., “T-Lymphocytes Expressing HECA-452 Epitope are Present in Cutaneous Acute Graft-Versus-Host Disease and Erythema Multiforme, but not in Acute Graft-Versus-Host Disease in Gut Organs,”Amer. J. Path.141(3):691-698 (1992).
Dimitroff CJ, et al., “A Distinct Glycoform of CD44 is an L-Selectin Ligand on Human Hematopoietic Progenitor Cells,”Proc. Natl. Acad. Sci.97(25), 13841-13846 (2000).
Dimitroff CJ, et al., “CD44 is a Major E-Electin Ligand on Human Hematopoietic Progenitor Cells,”J Cell Biol.153:1277-1286 (2001).
Dimitroff CJ, et al., “Differential L-Selectin Binding Activities of Human Hematopoietic Cell L-Selectin Ligands, HCELL and PSGL-1,”J. Biol. Chem.276(50):47623-47631 (2001).
Ellies LG, et al., “Core 2 Oligosaccharide Biosynthesis Distinguishes Between Selectin Ligands Essential for Leukocyte Homing and Inflammation,”Immunity9(6):881-890 (1998).
Erdmann I, et al., “Fucosyltransferase VII-Deficient Mice with Defective E-, P-, and L-Selectin Ligands Show Impaired CD4+ and CD8+ T Cell Migration Into the Skin, But Normal Extravasation Into Visceral Organs.”J. Immunol.168(5):2139-2146 (2002).
Fuhlbrigge RC, et al., “Cutaneous Lymphocyte Antigen is a Specialized Form of PSGL-1 Expressed on Skin-Homing T-Cells,”Nature389:978-981 (1997).
Heald PW, et al., “Skin-Selective Lymphocyte Homing Mechanisms in the Pathogenesis of Leukemic Cutaneous T-Cell Lymphoma,”J. Invest. Dermatol.101(2):222-226 (1993).
Homeister JW, et al., “The α(1,3)Fucosyltransferases FucT-IV and FucT-VII Exert Collaborative Control Over Selectin-Dependent Leukocyte Recruitment and Lymphocyte Homing,”Immunity15(1):115-126 (2001).
Kieffer JD, et al., “Neutrophils, Monocytes, and Dendritic Cells Express the Same Specialized Form of PSGL-1 as Do Skin-Homing Memory T Cells: Cutaneous Lymphocyte Antigen,”Biochem. Biophys. Res. Commun.285(3):577-587 (2001).
Kuan SF, et al., “Inhibition of Mucin GLycosylation by Aryl-N-acetyl-α-galactosamides in Human Colon Cancer Cells,”J. Biol Chem.264(32):19271-19277 (1989).
Kumar R, et al., “Core2 β-1,6-N-Aacetylglucosaminyltransferase Eenzyme Aactivity is Critical for P-Selectin Glycoprotein Ligand-1 Binding to P-Selectin,”Blood88:3872-3879 (1996).
Lowe JB, et al., “ELAM-1-Dependent Cell Adhesion to Vascular Endothelium Determined by a Transfected Human Fucosyltransferase cDNA,”Cell.63(3):475-484 (1990).
Maemura K, et al., “Poly-N-Acetyllactosaminyl O-glycans Attached to Leukosialin. The Presence of Sialyl Le(x) Structures in O-glycans,”J. Biol. Chem.267(34):24379-24386 (1992).
Maly P, et al., “The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking Through an Essential Role in L-, E-, and P-Selectin Ligand Biosynthesis,”Cell.86:643-653 (1996).
Mizukawa Y, et al., “Immunohistochemical Detection of Skin-Homing T Cells Expression Fucosyltransferase VII (Fuc-TVII) In Vitro and In Situ,”Lab. Invest.81(5):771-773 (2001).
Moore KL, et al., “The P-Selectin Glycoprotein Ligand From Human Neutrophils Displays Sialylated, Fucosylated, O-linked Poly-N-Acetyllactosamine,”J. Biol. Chem.269(37):23318-23327 (1994).
Nakamura M, et al. “UDP-GlcNAc:Galβ1→3Ga1NAc (GlcNAc to Ga1NAc) β1→6N-Acetylglucosaminyltransferase Holds a Key Role on the Control of CD15s Expression in Human Pre-B Lymphoid Cell Lines,”Glycobiology9(1):1-12 (1999).
Nakayama F, et al., “Expression of Cutaneous Lymphocyte-Associated Antigen Regulated by a Set of Glycosyltransferases in Human T Cells: Involvement of α1, 3-Fucosyltransferase VII and β1,4-Galactosyltransferase I,”J. Invest. Dermatol.115(2):299-306 (2000).
Niemela R, et al., “Complementary Acceptor and Site Specificities of Fuc-TIV and Fuc-TVII Allow Effective Biosynthesis of Sialyl-TriLex and Related Polylactosamines Present on Glycoprotein Counterreceptors of Selectins,”J. Biol. Chem.273(7):4021-4026 (1998).
Okajima T, et al. “Molecular Cloning of a Novel α2,3-Sialyltransferase (ST3Gal VI) That Sialylates Types II Lactosamine Structures on Glycoproteins and Glycolipids,”J. Biol. Chem.274(17):11479-11486 (1999).
Picker LJ, et al., “A Unique Phenotype of Skin-Associated Lymphocytes in Humans. Preferential Expression of the HECA-452 Epitope by Benign and Malignant T cells at Cutaneous Sites,”Amer. J. Path.136:1053-1068 (1990).
Picker LJ, et al., “Control of lymphocyte recirculation in man. II. Differential Regulation of the Cutaneous Lymphocyte-Associated Antigen, a Tissue-Selective Homing Receptor for Skin-Homing T Cells,”J. Immunol.150(3):1122-1136 (1993).
Piller F, et al., “Altered O-Glycan Synthesis in Lymphocytes from Patients with Wiskott-Aldrich Syndrome,”J Exp. Med.173(6):1501-1510 (1991).
Pinola M, et al., “Characterization of the E-Selectin Ligand on NK cells,”J. Immunol.152(7):3586-3594 (1994).
Robert C, et al., “Inflammatory Skin Diseases, T Cells, and Immune Surveillance,”New Engl. J. Med.341(24):1817-1828 (1999).
Rook AH, et al., “The Immunopathogenesis of Cutaneous T-Cell Lymphoma. Hemato,”Oncol. Clin. N. Amer.9:997-1010 (1995).
Rossiter H, et al., “Skin Disease-Related T-Cells Bind to Endothelial Selectins: Expression of Cutaneous Lymphocyte Antigen (CLA) Predicts E-Selectin But Not P-Selectin Binding,”Eur. J. Immuno.24:205-210 (1994).
Santamaria Babi LF, et al., “Circulating Allergen-Reactive T Cells from Patients With Atopic Dermatitis and Allergic Contact Dermatitis Express the Skin-Selective Homing Receptor, the Cutaneous Lymphocyte-Associated Antigen,”J. Exp. Med.181(5):1935-1940 (1995).
Sackstein R, et al., “A Hematopoietic Cell L-Selectin Ligand That is Distinct From PSGL-1 and Displays N-Glycan-Dependent Binding Activity,”Blood96:2765-2774 (2000).
Schmid K, et al., “Amino Acid Sequence of Human Plasma Galactoglycoprotein: Identity With the Extracellular Region of CD43 (Sialophorin),”Proc. Natl. Acad. Sci. U S A.89(2):663-667 (1992).
Sharma and Korytnyk, “Modifications at C-3 and C
Bernacki Ralph J.
Dimitroff Charles J.
Matta Khushi L.
Paul Brajeswar
Sackstein Robert
Fish & Richardson P.C.
Health Research , Inc.
Jiang Shaojia A.
Krishnan Ganapathy
The Brigham and Women's Hospital, Inc.
LandOfFree
Fluorinated glucosamine analogs useful for modulating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorinated glucosamine analogs useful for modulating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorinated glucosamine analogs useful for modulating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3605331